| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.27 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 9e-06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.16 | 0.4 |